HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...

Fintel reports that on November 18, 2024, HSBC upgraded their outlook for Moderna (NasdaqGS:MRNA) from Hold to Buy. Analyst ...

In addition to Berenberg Bank, Moderna also received a Hold from HSBC’s Yifeng Liu in a report issued yesterday. However, on the same day, Piper Sandler maintained a Buy rating on Moderna (NASDAQ: ...

Stocks climbed as Treasuries halted a selloff that drove 10-year yields near 4.5%, with traders keeping a close eye on news ...

Moderna (MRNA) closed up more than 7% after HSBC upgraded the stock to buy from hold with a price target of $58. Dell Technologies (DELL) closed up more than +3% after Mizuho Securities raised its ...

Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...

US stocks finished mixed on Monday ahead of a busy week for corporate earnings, though the Nasdaq managed to push higher, led by gains from Tesla.

Asian equities are poised to track Wall Street stocks higher as Treasuries halted a selloff that drove 10-year yields near ...

The Delhi High Court has asked the government to develop a comprehensive action plan, including a detailed Standard Operating Procedure (SOP), for addressing bomb threats and related emergencies ...

A view of the new Beijing Stock Exchange at the Financial Street, in Beijing, China, November 15, 2021. REUTERS/Tingshu Wang/File Photo Asian stocks rose on Tuesday while U.S. bond yields and the ...

A statement from The Right Revd Anthony Poggo, The Secretary General of the Anglican Communion, about the resignation of the Archbishop of Canterbury The steering committee of the International ...

Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 22,411.78 Crore) operating in Hospitals & Allied Services sector. Krishna ...